Dionne is the Head of Enterprise Public Sector Group in Microsoft Hong Kong, where she leads the core business growth for Government, quasi-government, healthcare, education and core infrastructure organisations in Hong Kong. She oversees all perspective of the business –– from transformation strategy and executive engagement to talent development –– driving innovation and impact across Hong Kong’s public sector landscape.

With over a decade of experience at Microsoft, Dionne has held various leadership roles spanning public sector and enterprises, including conglomerates, financial services and more. Prior to this role, she served as the Head of Sales of Cisco Hong Kong, where she led enterprise, education, and healthcare engagement. Her customer-centric approach and outstanding performance have earned her numerous accolades, including global Hall of Fame and Chairman’s Club awards, as well as recognition from the Hong Kong Computer Society as the ICT Award Winner.

Beyond her corporate achievements, Dionne is a passionate advocate for community empowerment. She actively supports underprivileged communities through her fundraising work with the Wai Yin Association Charity.

Dionne holds a Bachelor’s degree in Engineering from the Hong Kong University of Science and Technology and MBA from the University of Hong Kong.

Mr. Yeung held management positions in financial advisory department of Deloitte China for many years. He served as the National Managing Partner of Financial Advisory of Deloitte China from November 2013 to May 2021 and was appointed as the Vice Chairman of Deloitte China since June 2021. Before Mr. Yeung stepped down from Deloitte China, he led the team in capital market advisory, debt restructuring, fund advisory, forensic accounting investigation, corporate restructuring, etc. and advised corporate clients and investors both on the Chinese mainland and Hong Kong on various investment projects, acquisitions and mergers projects.

Elsa Zheng comes from the Cross-border Investment Department of China Merchants Bank Capital. Her main focus is on global infrastructure, cross-border mergers and acquisitions, private credit and private equity investments in the process of Chinese enterprises going global. The management scale of China Merchants Bank Capital is approximately 43 Billion USD, and it is one of the leadering alternative investment and asset management instritutions in Asia.

Mr. Henry Haijian He has served as chief financial officer of Baidu and the chairman of the board of directors of iQIYI, Inc. since July 2025. Mr. He joined Baidu from Kingsoft Cloud Holdings Limited where he served as executive director and chief financial officer since January 2020.

Prior to joining Kingsoft Cloud, Mr. He served as an executive director of the TMT (telecommunications, media and technology) group and the mergers and acquisitions group sequentially at Goldman Sachs (Asia) L.L.C. from September 2015 to January 2020. Mr. He has extensive experience in complex merger and acquisition transactions and headed Asia M&A department at Goldman Sachs. Prior to that, Mr. He worked at Bank of America Merrill Lynch and Citigroup Global Markets Inc. successively from 2010 to 2015.

Mr. He currently serves as an independent non-executive director of Sipai Health Technology Co., Ltd. and Sunwoda EVB Co., Ltd.

Mr. He received his bachelor’s degree and master’s degree in electronic engineering from Southeast University and an MBA from University of Chicago, and completed Advanced Management Program (AMP) at Harvard Business School. Mr. He is also a Chartered Financial Analyst charter holder.

James is the Head of International Wealth Management at KGI. He oversees and leads both the International Wealth Management Department and the Investment Products and Services Department. In this role, he is responsible for developing growth strategies for high-net-worth clients, expanding KGI's presence in the Asian market, and delivering customised wealth and investment products, solutions, and platforms.

Before joining KGI, James spent 15 years at J.P. Morgan Wealth Management, where he rose from a client coverage advisor to a Market Manager and eventually to a Regional Head, overseeing the firm's operations in Singapore and Southeast Asia. Prior to this, he was also a management consultant at McKinsey & Company.

James holds a Bachelor of Science degree from Brown University in Rhode Island, USA, majoring in Neuroscience. He obtained his MBA from Duke University in North Carolina, USA, majoring in Finance.

Mr. Jeffrey Ng is Group Chief Communications Officer and a member of the Management Committee at Hong Kong Exchanges and Clearing Limited (HKEX), leading the exchange group’s corporate affairs and stakeholder engagement functions. He joined HKEX in 2017 and was previously HKEX’s Head of Media and Government Relations.

Before joining HKEX, Mr. Ng was a journalist at Dow Jones Newswires and The Wall Street Journal, where for over 13 years he directed teams of editors and reporters across the Asia-Pacific region in roles including Asia Editor for Newswires, Asia Transportation Editor and Hong Kong Bureau Chief. He has a Bachelor of Science in international political economy from Georgetown University in Washington, DC, a Juris Doctor from The Chinese University of Hong Kong, and a Postgraduate Certificate in Laws from the University of Hong Kong.

Mr. Ng is a Vice Chair at the Canadian International School of Hong Kong (CDNIS), and chairs the school’s Audit Committee.  

‍

Mr. Chan has over 40 years of experience in the investment banking and investment management industry. He is the Chief Investment Officer (CIO) of the Cyberport Macro Fund for the Hong Kong Cyberport Management Company.

He has been appointed as a member of the Exchange Fund Advisory Committee of the Hong Kong Monetary Authority (EFAC), chaired by the Financial Secretary, and as a member of the Investment Sub-Committee and Governance Sub-Committee since September 2025. Mr. Chan has been a Non-Executive Director of the Accounting and Financial Reporting Council (AFRC) since October 2024 and serves on its Disciplinary Committee and Finance and Corporate Affairs Committee. He is a member of the Market Misconduct Tribunal and a panel member of the Securities and Futures Appeals Tribunal. He served on the Advisory Panel for the Blockchain and Digital Asset Pilot Subsidy Scheme from August 2025 to January 2026.

Mr. Chan assumed the Chairmanship of the Global Venture Capital Congress (GVCC) in 2024. The GVCC is an international body that brings together the world’s leading venture capital and private equity associations. Its purpose is to foster collaboration and knowledge sharing among industry leaders, promoting the development of the global direct investment industry. He also serves as President of the Hong Kong Private Equity and Venture Capital Association (Chairman, 2007–2011), the largest association of its kind in Asia by membership and activities. He also acts as a Senior Advisor to the HSBC Strategic Venture Capital Fund within the Global Asset Management Division.

Mr. Chan serves as an Independent Non-Executive Director of: Hangzhou SF Intra-city Industrial Co., Ltd.; NetEase Inc.; CNQC International Holdings Limited; HSBC Provident Fund Trustee (Hong Kong) Limited (Chairman of its Investment Committee), a wholly owned subsidiary of HSBC Holdings; and Quantinuum K.K. (Japan).

Mr. Chan was a Member of the Listing Committee of The Stock Exchange of Hong Kong Limited from July 2020 to July 2022, and served as its Deputy Chairman from July 2022 to July 2024. He served as an Advisor to the Vice Minister of Finance at the Ministry of Finance of the Kingdom of Thailand from 2016 to 2018.

‍

Dr. Joseph Chan is Chief Medical Officer of HKSH Medical Group and Deputy Medical Superintendent of Hong Kong Sanatorium & Hospital. He leads doctor credentialling for world-class expertise and patient safety, pioneers price transparency to empower informed choices, and advances value-based care balancing quality, affordability and sustainability. He spearheads primary and community care expansion, integrating hospital, ambulatory and outpatient services for seamless patient pathways. As Director of the HKSH Institute for Innovation and Professional Development, established in 2024, he drives education, research and talent pipelines through university partnerships, while having established medical student and postgraduate training programs at HKSH for Hong Kong’s medical schools. Dr Chan serves as Vice Chairman of the Hong Kong Private Hospitals Association, shaping policy on regulation, quality and innovation to foster public-private collaboration. He is a former Honorary Treasurer of the Hong Kong College of Obstetricians and Gynaecologists, currently chairing its Gynaecological Endoscopic Surgery Subcommittee and serving on its Quality Assurance Committee. A University of Hong Kong medical graduate (1975), he trained in the UK, earning MRCOG (1981), FHKAM (O&G, 1993), FRCOG (1996) and EMBA (CUHK, 2010). He is an Obstetrics & Gynaecology Specialist, Honorary Clinical Associate Professor in Obstetrics & Gynaecology of The University of Hong Kong, a Fellow of Hong Kong College of Health Service Executives and a Fellow of Australasian College of Health Service Management.Dr Chan is a St John’s Cathedral Church Council Member, and Chief Volunteer of HKSH Village Volunteers, leading NGO fundraising and elderly support. His dedication to corporate social responsibility reflects his belief that healthcare leadership should extend compassion beyond the clinic, enriching lives and strengthening community well‑being.

Karen Chan joined DFI Retail Group in April 2024 as Investor Relations Director and was appointed Strategy and Investor Relations Director in August 2025. She is responsible for leading the Group’s strategic planning process and overseeing investor relations, including strategic development, execution and performance tracking. Karen also plays a key role in shaping the company’s corporate narrative and shareholder return strategy.

Karen has over 15 years of experience spanning investor relations, equity research, and asset management across Hong Kong, China, and the United States. She has extensive experience in corporate strategy, capital allocation, financial analysis, and communicating corporate strategy and financial performance to global investors. Prior to joining DFI, Karen served as Vice President, Investor Relations at IMAX China, where she worked closely with senior management on long-term financial planning, capital allocation strategy, and investor communications.

Earlier in her career, Karen was a Senior Vice President and Head of Hong Kong/China Internet Research at Jefferies, where she led coverage of major China internet companies and engaged closely with global institutional investors. She began her career in the United States as an Equity Research Associate at Trust Company of the West in Los Angeles, focusing on the healthcare and technology sectors.

Karen holds a Bachelor of Arts in Business Economics from the University of California, Los Angeles, where she graduated Summa Cum Laude. She is also a CFA Charterholder.

Kevin Huang is the Chief Operating Officer of the South China Morning Post and is responsible for Advertising & Marketing Solutions, Events and Corporate Communications at the Post. Kevin’s career spans more than 25 years across Asia Pacific, during which he has consistently spearheaded digital, mobile and advertising businesses through high growth and profitability. Prior to joining SCMP, Kevin was the Managing Director of Carousell. Before that, he headed Birdie Mobile, Hong Kong’s first digital-only operator. Kevin was also the Co-founder and CEO of Pixels, and grew the company to become one of the leading home-grown adtech firms in the region. Kevin is a founding member and the Immediate Past Chairman of the Interactive Advertising Bureau (IAB) Hong Kong. He holds a degree in Computer Information Systems from Pace University. Born in Malaysia, Kevin has been living and working in Hong Kong for over two decades.

Ms. Liza Ko is the Chief Financial Officer of MingMed Biotechnology, with over 20 years of distinguished expertise in accounting, finance and regulatory affairs within the biotechnology and capital markets sectors. Prior to joining MingMed in 2021, Ms. Ko served as Vice President in the Listing Division of Hong Kong Exchanges and Clearing Limited (HKEX). During her tenure at HKEX since 2011, she led and supervised teams responsible for conducting rigorous due diligence on pre-listing enquiries, determining the eligibility and suitability of prospective issuers, and shaping market guidance on the interpretation and application of the HKEX Listing Rules. Before her regulatory career, Ms. Ko developed deep technical expertise at KPMG LLP, where she provided accounting and auditing services to U.S. and Singapore-listed companies in complex, multi-jurisdictional environments. Ms. Ko holds a Bachelor ’s degree in Accounting from Nanyang Technological University in Singapore.